The company brought back Chairman and former CEO Stephen Hemsley for the top role, saying Andrew Witty has resigned “for ...

The U.S. Department of Justice (DOJ) has reportedly rejected Amedisys’ (Nasdaq: AMED) and UnitedHealth Group’s (NYSE: UNH) attempt to divest assets, a ...

The Department of Justice reportedly has rejected Amedisys’ plan to divest more than 100 locations in its plan to be acquired ...

Amedisys earlier ticked down 0.2% on a report that the Dept. of Justice has initially rejected the proposed divestiture ...

Detailed price information for Astrana Health Inc (ASTH-Q) from The Globe and Mail including charting and trades.

For those who have been following the U.S. Department of Justice’s (DOJ) legal battle against UnitedHealth Group (NYSE: UNH) ...

Healthcare mergers and acquisitions are in no short supply as providers, health tech companies, retailers and other industry ...

Specifically, the researchers observed that higher alternative-Mediterranean diet (aMED) scores were associated with a 28% ...

The sales are contingent on the closure of UnitedHealth’s acquisition of Amedisys, which has been held up after the ...

A cross-sectional analysis of adults examined how newly identified age-, sex-, and race-specific reference intervals for thyroid function diagnostic tests reclassify people into different disease ...

MilliporeSigma says the extra fees, which will take effect Monday, are a direct response to President Donald Trump's tariffs. The company is owned by Merck KGaA, which is based in Germany.

UnitedHealth Group and Amedisys have found buyers for key divestitures aimed at getting their $3.3 billion merger over the ...